Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZT-031 in hip fracture healing
NCT00787358Phase 2Withdrawn
- Sponsor
- Zelos Therapeutics
- Start
- Dec 2008
- Primary completion
- Jun 2009
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ostabolin-c in hip fracture, sponsored by Zelos Therapeutics. Planned start Dec 2008; status: withdrawn.
02
Drugs
ostabolin-c
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT00787358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00787358.